主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
HRMY
#1797
Harmony Biosciences Holdings, Inc. Common Stock
28.540
0
+0.25%
版块:
基础:
利润货币:
日范围
年范围
日变化
+0.25%
每月变动
-24.24%
6个月变化
-7.64%
年变化
-7.64%
前一天收盘价
28.470
0
Open
28.540
0
Bid
Ask
Low
28.540
0
High
28.540
0
交易量
110
市场
股票
医疗保健
HRMY
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
57.03 M
57.35 M
57.42 M
57.53 M
57.6 M
57.84 M
—
Valuation ratios
Enterprise value
1.89 B
1.52 B
1.42 B
1.27 B
940.36 M
1.41 B
5.04 B
Price to earnings ratio
18.87
13.71
12.67
10.19
8.67
13.81
45.34
Price to sales ratio
3.42
2.79
2.58
2.38
1.95
2.52
9.44
Price to cash flow ratio
10.63
9.06
8.64
7.09
5.41
6.29
27.43
Price to book ratio
1.1
3.02
0.77
0.67
0.54
2.52
4.49
Enterprise value to EBITDA ratio
8.78
7.12
6.02
4.85
3.53
6.1
20.5
Profitability ratios
Return on assets %
0.05
0.05
0.04
0.04
0.04
0.02
0.14
Return on equity %
0.08
0.08
0.06
0.05
0.06
0.03
0.2
Return on invested capital %
41.64
43.28
36.37
29.77
39.61
19.07
124.81
Gross margin %
77.01
72.97
82.68
80.97
75.09
71.88
310.62
Operating margin %
33.17
27.69
30.45
24.03
27.35
15.82
97.64
EBITDA margin %
36.18
39.38
33.52
26.86
29.77
25.55
115.7
Net margin %
24.78
24.58
24.66
19.84
21.24
9.22
74.97
Liquidity ratios
Quick ratio
3.2
3.27
3.63
3.8
3.72
3.58
14.74
Current ratio
3.24
3.31
3.67
3.84
3.75
3.6
14.86
Inventory turnover
6.81
7.71
4.71
6.11
9.19
11.2
31.21
Asset turnover
0.21
0.21
0.18
0.19
0.21
0.2
0.77
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
0.18
0.16
0.15
0.14
0.12
0.11
0.52
Long term debt to total equity ratio
0.28
0.25
0.22
0.2
0.18
0.17
0.76
Per share metrics
Operating cash flow per share
1.21
1.31
0.58
1.36
1.85
2.15
5.95
EBIT per share
1.06
0.96
0.96
0.82
1.12
0.66
3.56
EBITDA per share
1.16
1.37
1.06
0.92
1.21
1.06
4.26
Total debt per share
—
—
—
—
—
—
—
Cash per share
7.06
8.07
8.66
9.67
11.45
13.24
43.04
Net current asset value per share
8.99
10.01
10.98
11.83
14.29
15.49
52.59
Tangible book value per share
8.22
9.43
10.48
11.5
12.6
13.34
47.91
Working capital per share
6.22
6.98
7.99
8.75
10.48
11.19
38.41
Book value per share
10.27
11.39
12.31
13.23
14.22
14.86
54.63
新闻
BEAM's Q4 Loss Narrower Than Expected, Revenues Rise Y/Y
IOVA Beats on Q4 Earnings & Sales, Stock Soars on Pipeline Progress
RXRX Q4 Loss Narrower Than Expected, Revenues Increase Y/Y, Stock Up
Corcept's Q4 Earnings and Revenues Fall Short of Estimates
Repligen's Q4 Earnings Beat Estimates, Revenues Surge Y/Y
Apellis Q4 Loss Wider Than Expected, Revenues Decline Y/Y
瑞银因Wakix仿制药提前上市下调Harmony Biosciences目标价
UBS cuts Harmony Biosciences stock price target on earlier Wakix generic entry
Truist重申对Harmony Biosciences股票的持有评级,目标价25美元
Truist reiterates Hold on Harmony Biosciences stock, sets $25 target
AXSM Q4 Loss Wider Than Expected, Revenues Surge Y/Y on Auvelity Sales
BMRN Beats on Q4 Earnings, to Withdraw Roctavian From Market